(Q54015209)

23 May 2018

title

A possible role for methotrexate in the treatment of childhood acute myeloid leukaemia, in particular for acute monocytic leukaemia. (English)

1 reference

23 May 2018

1 reference

1 reference

Rots MG

1

1 reference

23 May 2018

Pieters R

2

1 reference

23 May 2018

Jansen G

3

1 reference

23 May 2018

Kaspers GJ

4

1 reference

23 May 2018

Van Zantwijk CH

5

1 reference

23 May 2018

Noordhuis P

6

1 reference

23 May 2018

Voorn DA

7

1 reference

23 May 2018

Van Wering ER

8

1 reference

23 May 2018

Creutzig U

9

1 reference

23 May 2018

Veerman AJ

10

1 reference

23 May 2018

Peters GJ

11

1 reference

23 May 2018

publication date

1 March 2001

1 reference

23 May 2018

European Journal of Cancer

published in

1 reference

23 May 2018

volume

37

1 reference

23 May 2018

issue

4

1 reference

23 May 2018

page(s)

492-498

1 reference

23 May 2018

Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood. Pediatric Oncology Group

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900433-0

7 January 2021

Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukemia: results of the United Kingdom Medical Research Council's 10th AML trial. MRC Childhood Leukaemia Working Party.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900433-0

7 January 2021

Acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900433-0

7 January 2021

Cellular drug resistance in acute myeloid leukemia: literature review and preliminary analysis of an ongoing collaborative study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900433-0

7 January 2021

Anti-folate resistance in leukemia: treatment with “high-dose” methotrexate and citrovorum factor

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900433-0

7 January 2021

Basis for natural resistance to methotrexate in human acute non-lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900433-0

7 January 2021

Heterogeneity in the specific activity and methotrexate sensitivity of dihydrofolate reductase from blast cells of acute myelogenous leukemia patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900433-0

7 January 2021

Increased methotrexate polyglutamylation in acute megakaryocytic leukemia (M7) compared to other subtypes of acute myelocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900433-0

7 January 2021

Topoisomerase II inhibitor-related acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900433-0

7 January 2021

Proposals for the Classification of the Acute Leukaemias French-American-British (FAB) Co-operative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900433-0

7 January 2021

Mononuclear cells contaminating acute lymphoblastic leukaemic samples tested for cellular drug resistance using the methyl-thiazol-tetrazolium assay

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900433-0

7 January 2021

Distinguishing between folate receptor-alpha-mediated transport and reduced folate carrier-mediated transport in L1210 leukemia cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900433-0

7 January 2021

Importance of pharmacodynamics in the in vitro antiproliferative activity of the antifolates methotrexate and 10-ethyl-10-deazaaminopterin against human head and neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900433-0

7 January 2021

Comparison of methotrexate polyglutamylation in L1210 leukemia cells when influx is mediated by the reduced folate carrier or the folate receptor. Lack of evidence for influx route-specific effects

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900433-0

7 January 2021

Regulation of carrier-mediated transport of folates and antifolates in methotrexate-sensitive and-resistant leukemia cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900433-0

7 January 2021

A structurally altered human reduced folate carrier with increased folic acid transport mediates a novel mechanism of antifolate resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900433-0

7 January 2021

MRP3, an organic anion transporter able to transport anti-cancer drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900433-0

7 January 2021

Purification and properties of human cytosolic folylpoly-gamma-glutamate synthetase and organization, localization, and differential splicing of its gene

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900433-0

7 January 2021

10.1016/S0959-8049(00)00433-0

Identifiers

DOI

1 reference

23 May 2018

PubMed ID

11267859

1 reference

23 May 2018